204 related articles for article (PubMed ID: 33475060)
1. A Review on Exploring Better Safety Prospects in Managing Cancer using Liposomal Combinations of Food Bioactive Compounds and Anticancer Drugs: Combisomes.
Dubey A; Shriram RG; El-Zahaby SA
Curr Drug Deliv; 2021 Sep; 18(8):1105-1120. PubMed ID: 33475060
[TBL] [Abstract][Full Text] [Related]
2. Liposomal Drug Delivery Systems and Anticancer Drugs.
Olusanya TOB; Haj Ahmad RR; Ibegbu DM; Smith JR; Elkordy AA
Molecules; 2018 Apr; 23(4):. PubMed ID: 29662019
[TBL] [Abstract][Full Text] [Related]
3. Liposomes Co- encapsulating Anticancer Drugs in Synergistic Ratios as an Approach to Promote Increased Efficacy and Greater Safety.
Franco MS; Oliveira MC
Anticancer Agents Med Chem; 2019; 19(1):17-28. PubMed ID: 29692263
[TBL] [Abstract][Full Text] [Related]
4. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
5. Advances in the Application of Liposomal Nanosystems in Anticancer Therapy.
Xiao D; Zhou R
Curr Stem Cell Res Ther; 2021; 16(1):14-22. PubMed ID: 32324519
[TBL] [Abstract][Full Text] [Related]
6. Updates on the use of liposomes for active tumor targeting in cancer therapy.
Yan W; Leung SS; To KK
Nanomedicine (Lond); 2020 Feb; 15(3):303-318. PubMed ID: 31802702
[TBL] [Abstract][Full Text] [Related]
7. Combination Cancer Therapy Using Multifunctional Liposomes.
Jain A; Tiwari A; Verma A; Saraf S; Jain SK
Crit Rev Ther Drug Carrier Syst; 2020; 37(2):105-134. PubMed ID: 32865902
[TBL] [Abstract][Full Text] [Related]
8. Safety of novel liposomal drugs for cancer treatment: Advances and prospects.
He K; Tang M
Chem Biol Interact; 2018 Nov; 295():13-19. PubMed ID: 28919304
[TBL] [Abstract][Full Text] [Related]
9. Development of Oral Delivery Systems with Enhanced Antioxidant and Anticancer Activity: Coix Seed Oil and β-Carotene Coloaded Liposomes.
Bai C; Zheng J; Zhao L; Chen L; Xiong H; McClements DJ
J Agric Food Chem; 2019 Jan; 67(1):406-414. PubMed ID: 30566345
[TBL] [Abstract][Full Text] [Related]
10. New generation of liposomal drugs for cancer.
Minko T; Pakunlu RI; Wang Y; Khandare JJ; Saad M
Anticancer Agents Med Chem; 2006 Nov; 6(6):537-52. PubMed ID: 17100558
[TBL] [Abstract][Full Text] [Related]
11. Liposome Delivery Systems for Inhalation: A Critical Review Highlighting Formulation Issues and Anticancer Applications.
Rudokas M; Najlah M; Alhnan MA; Elhissi A
Med Princ Pract; 2016; 25 Suppl 2(Suppl 2):60-72. PubMed ID: 26938856
[TBL] [Abstract][Full Text] [Related]
12. Clinical application of drug delivery systems in cancer chemotherapy: review of the efficacy and side effects of approved drugs.
Iwamoto T
Biol Pharm Bull; 2013; 36(5):715-8. PubMed ID: 23649331
[TBL] [Abstract][Full Text] [Related]
13. Phytochemical-loaded liposomes for anticancer therapy: an updated review.
Chavda VP; Vihol D; Mehta B; Shah D; Patel M; Vora LK; Pereira-Silva M; Paiva-Santos AC
Nanomedicine (Lond); 2022 Apr; 17(8):547-568. PubMed ID: 35259920
[TBL] [Abstract][Full Text] [Related]
14. Development of liposomal anticancer drugs.
Hyodo K; Yamamoto E; Suzuki T; Kikuchi H; Asano M; Ishihara H
Biol Pharm Bull; 2013; 36(5):703-7. PubMed ID: 23649329
[TBL] [Abstract][Full Text] [Related]
15. Nano-sized polymers and liposomes designed to deliver combination therapy for cancer.
Eldar-Boock A; Polyak D; Scomparin A; Satchi-Fainaro R
Curr Opin Biotechnol; 2013 Aug; 24(4):682-9. PubMed ID: 23726153
[TBL] [Abstract][Full Text] [Related]
16. Triggered activation and release of liposomal prodrugs and drugs in cancer tissue by secretory phospholipase A2.
Andresen TL; Jensen SS; Kaasgaard T; Jørgensen K
Curr Drug Deliv; 2005 Oct; 2(4):353-62. PubMed ID: 16305438
[TBL] [Abstract][Full Text] [Related]
17. Liposomal forms of anticancer agents beyond anthracyclines: present and future perspectives.
Papachristos A; Pippa N; Ioannidis K; Sivolapenko G; Demetzos C
J Liposome Res; 2015; 25(2):166-73. PubMed ID: 25148295
[TBL] [Abstract][Full Text] [Related]
18. Passive and active targeting in cancer therapy by liposomes and lipid nanoparticles.
Alavi M; Hamidi M
Drug Metab Pers Ther; 2019 Feb; 34(1):. PubMed ID: 30707682
[TBL] [Abstract][Full Text] [Related]
19. Targeting anticancer drugs to tumor vasculature using cationic liposomes.
Abu Lila AS; Ishida T; Kiwada H
Pharm Res; 2010 Jul; 27(7):1171-83. PubMed ID: 20333455
[TBL] [Abstract][Full Text] [Related]
20. Future developments in the selectivity of anticancer agents: drug delivery and molecular target strategies.
Mayer LD
Cancer Metastasis Rev; 1998 Jun; 17(2):211-8. PubMed ID: 9770118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
